LL-37



LL-37

L1LL1L2LL2G3GG3D4DD4F5FF5F6FF6R7RR7K8KK8S9SS9K10KK10E11EE11K12KK12I13II13G14GG14K15KK15E16EE16F17FF17K18KK18R19RR19I20II20V21VV21Q22QQ22R23RR23I24II24K25KK25D26DD26F27FF27L28LL28R29RR29N30NN30L31LL31V32VV32P33PP33R34RR34T35TT35E36EE36S37SS37

SMILES None
InChIKey POIUWJQBRNEFGX-XAMSXPGMSA-N
Sequence LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


No bioactivity data available.

LL-37

L1LL1L2LL2G3GG3D4DD4F5FF5F6FF6R7RR7K8KK8S9SS9K10KK10E11EE11K12KK12I13II13G14GG14K15KK15E16EE16F17FF17K18KK18R19RR19I20II20V21VV21Q22QQ22R23RR23I24II24K25KK25D26DD26F27FF27L28LL28R29RR29N30NN30L31LL31V32VV32P33PP33R34RR34T35TT35E36EE36S37SS37

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.